Sinkala et al. perform an integrated pan-cancer analysis of 10,528 tumors from 32 cancer types and 825 human cancer cell lines to identify metabolic pathways associated with anti-cancer drug responses and clinical outcomes. This study suggests that metabolic features associated with specific cancer types may be used to effectively target these cancers.
- Musalula Sinkala
- Nicola Mulder
- Darren Patrick Martin